Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Eikon Therapeutics

Request full access

Pioneering a new method of drug discovery based on tracking and measuring movement of individual proteins in live cells

Hayward, United StatesFounded 2019Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2026

Eikon Therapeutics in the Hayward ecosystem

Live from Dealroom

The Eikon Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

24 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A3 investors entered at this stage

Series B and later20 investors entered at this stage

Ownership

Share of equity by holder

Share of equity by holder, from Dealroom's shareholder data. Stakes as last recorded by Dealroom (May/2026).

34.6% Founders

See the full cap table on Dealroom →

Employees mapped 435 incl. 9 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 11 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$36M

58 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Eikon Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.